Top Investment Manager Analyzes Latest Financial Results of Leading Companies
Leading pharmaceutical company, Moberg Pharma, reported a net loss of -4.0 million SEK for the second quarter of 2024 (-3.9).
The net revenue amounted to 4.1 million SEK (0). The operating profit was -5.5 million SEK (-5.3). Ebitda stood at -5.2 million SEK (-4.7).
The company’s cash position was at 326 million SEK (52).
Oil company Maha Energy’s ebitda result was -0.9 million USD in the second quarter of 2024 (-1.1).
The net income was -22.7 million USD (0.7), equivalent to -0.13 USD per share (0.00). The net revenue reached 2.2 million USD (1.3).
Revolutionrace, a leading online retailer of outdoor clothing, reported an operating profit of 74 million SEK for the fourth quarter (April-June) of the fiscal year 2023/2024.
The operating margin was 18.3% (18.9), while the gross margin was 71.9% (74.5). The net revenue reached 407 million SEK (362). The average order value (AOV) was 939 SEK (842).
The proposed dividend is 1.20 SEK per share (0.86).
Specialty pharmaceutical company, Calliditas, reported an operating profit of -31.5 million SEK for the second quarter of 2024 (-75.2).
The net loss was -47.5 million SEK (-91.9), with an earnings per share of -0.88 SEK (-1.71). The net revenue was 560 million SEK (269), with Tarpeyo sales for the treatment of a rare kidney disease reaching 493 million SEK (259).
Analysis: In summary, Moberg Pharma, Maha Energy, Revolutionrace, and Calliditas have all reported their financial results for the recent quarter. While Moberg Pharma and Calliditas saw some losses, Revolutionrace showed a strong performance with increased revenue and profits. Investors should keep an eye on these companies for potential investment opportunities based on their financial health and growth prospects.